Clinical Trial: Clinical Study on the Efficacy and Safety of Medical Recombinant Composite Protein Combined with Fractional CO₂ Laser in the Treatment of Atrophic Acne Scars (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study on the Efficacy and Safety of Medical Recombinant Composite Protein Combined with Fractional CO₂ Laser in the Treatment of Atrophic Acne Scars'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132470

Registration Time: 2026/09/15

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340221

Published by HT Digital Content Services with permission from Health Daily Digest....